- About the Center
- Patient Care
- Community Outreach
- Academic Programs
- News & Media
Researchers and clinicians at the University of Arizona Cancer Center are responsible for countless scientific breakthroughs. These advances, however, are just the first steps toward achieving the ultimate goal — to prevent and cure cancer.
While Thomas Grogan, MD, was in the process of redefining tissue analysis, he teamed up with a clinical oncologist in Thomas Miller, MD, to see how they could effectively turn their lymphoma-based research into life-saving therapies.
Early in the 21st century, the National Cancer Institute hoped to establish personalized treatment as the standard of care. The team at the University of Arizona Cancer Center began exploring the concept of “personalized cancer care” in the mid-1970s.
While successful cancer research requires an analytical, detail-oriented mind, the truly transcendent work in the field comes as a result of an adventurous spirit and a flair for the dramatic.
Yves A. Lussier, MD, FAMCI, a professional engineer and physician-scientist who conducts research in translational bioinformatics and personal genomics, has joined the University of Arizona Cancer Center.
Thomas P. Miller, MD, has been named the director of the Division of Hematology/Oncology in the UA College of Medicine’s Department of Medicine.
University of Arizona Cancer Center member Gregory Rogers, PhD, has recently published a paper in the journal Current Biology, highlighting his laboratory’s innovative work exploring the link between the Polo-like kinase 4 (Plk4) protein levels and chromosomal instability (CIN), which can contribute to the formation of cancer.
University of Arizona Cancer Center member Donato Romagnolo, PhD, MSc, is leading a study that suggests that external environmental and dietary factors in pregnant women may have an impact on future breast cancer risk for the offspring.